Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 8/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.34 |
| ▸ | DRD2 | P14416 | 7/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21681741 | 0.90 | ALOX15 (0.38) | ALOX15DRD3DRD2 | |
| SCHEMBL10851707 | 0.89 | PER2 (0.33) | ALOX15DRD3KCNH2 | |
| SCHEMBL10868666 | 0.89 | ALOX15 (0.33) | ALOX15DRD3KCNH2POLBCYP2D6 | |
| SCHEMBL10849278 | 0.89 | L3MBTL1 (0.37) | ALOX15DRD3KCNH2POLBKMT2A | |
| SCHEMBL21711072 | 0.87 | ACE2 (0.43) | ALOX15KMT2A | |
| SCHEMBL1447298 | 0.85 | ALOX15 (0.35) | ALOX15DRD3DRD2 | |
| SCHEMBL10850120 | 0.85 | MEN1 (0.39) | KMT2A | |
| SCHEMBL9190064 | 0.84 | KEAP1 (0.38) | ALOX15DRD3KCNH2DRD2CYP2D6 | |
| SCHEMBL20656064 | 0.83 | ACE2 (0.50) | ALOX15CYP2C19KMT2A | |
| SCHEMBL10854804 | 0.83 | GBA1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11135544-B2 | Acidic gas absorbent, acidic gas removal method and acidic gas removal apparatus | KABUSHIKI KAISHA TOSHIBA (JP) | 2021-10-05 | — | — | US | claimed |
| EP-3414223-B1 | PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | NOURYON CHEMICALS INT BV (NL) | 2021-04-07 | — | — | EP | claimed |
| US-20200047110-A1 | ACIDIC GAS ABSORBENT, ACIDIC GAS REMOVAL METHOD AND ACIDIC GAS REMOVAL APPARATUS | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-02-13 | — | — | US | claimed |
| US-20190039994-A1 | PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2019-02-07 | — | — | US | claimed |
| EP-2649112-B1 | PRODUCTION OF AN ARTICLE BY SELECTIVE FUSION OF POLYMER POWDER LAYERS | RHODIA OPERATIONS (FR) | 2018-03-21 | — | — | EP | claimed |
| EP-2734507-B1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | ALLNEX IP S À R L (LU) | 2017-05-31 | — | — | EP | claimed |
| US-9321192-B2 | Production of an article by selective fusion of polymer powder layers | RHODIA OPERATIONS (FR) | 2016-04-26 | — | — | US | claimed |
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | ALLNEX USA INC. (US) | 2014-06-26 | — | — | US | claimed |
| US-20130307196-A1 | PRODUCTION OF AN ARTICLE BY SELECTIVE FUSION OF POLYMER POWDER LAYERS | RHODIA OPERATIONS (FR) | 2013-11-21 | — | — | US | claimed |
| US-11697735-B2 | Solid oleaginous compositions | TOTAL MARKETING SERVICES (FR) | 2023-07-11 | — | — | US | disclosed |
| US-11697735-B2 | Solid oleaginous compositions | TOTAL MARKETING SERVICES (FR) | 2023-07-11 | — | — | US | disclosed |
| US-11365317-B2 | Solid binders | TOTAL MARKETING SERVICES (FR) | 2022-06-21 | — | — | US | disclosed |
| EP-3612616-B1 | SOLID BITUMEN AT AMBIENT TEMPERATURE | TOTAL MARKETING SERVICES (FR) | 2022-06-01 | — | — | EP | disclosed |
| US-11339116-B2 | Reactive separation process to convert cyclic alkylene ureas into their corresponding alkylene amines | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-05-24 | — | — | US | disclosed |
| EP-0687288-A1 | MANNICH CONDENSATION PRODUCTS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ESTERS AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995029971-A1 | MANNICH CONDENSATION PRODUCTS OF POLY(OXYALKYLENE) HYDROXYAROMATIC CARBAMATES AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| WO-1995018197-A1 | MANNICH CONDENSATION PRODUCTS OF POLY(OXYALKYLENE) HYDROXYAROMATIC ESTERS AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |
| EP-0658573-A2 | Mannich condensation products of polyalkylene hydroxyaromatic esters and fuel compositions containing the same | CHEVRON CHEMICAL COMPANY (US) | 1995-06-21 | — | — | EP | disclosed |
| US-5413614-A | Antideposit | CHEVRON CHEMICAL COMPANY (US) | 1995-05-09 | — | — | US | disclosed |
| US-5399178-A | Antideposit agents | CHEVRON CHEMICAL COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190039994-A1 | PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | UBE2I, NAT10, UBE2M | ALOX15 2964/4885DRD3 2159/4885KCNH2 1358/4885 |
| US-11339116-B2 | Reactive separation process to convert cyclic alkylene ureas into their corresponding alkylene amines | UTP20, CGAS, UMPS | ALOX15 2542/4885DRD3 1979/4885KCNH2 1338/4885 |
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | CA4, CA2, CDYL | ALOX15 4231/4885DRD3 1747/4885KCNH2 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.